TFCM
TEVA icon

Taylor Frigon Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Taylor Frigon Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$3K Buy
69
+52
+306% +$2.77K ﹤0.01% 88
2016
Q1 		$1K Hold
17
– – ﹤0.01% 87
2015
Q4 		$1K Buy
+17
New +$1.05K ﹤0.01% 87

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Taylor Frigon Capital Management's TEVA Position: Q2 2016 in Review

Taylor Frigon Capital Management increased its Teva Pharmaceuticals (TEVA) stake by 306% in Q2 2016, buying an estimated $2.77K and bringing the position to 69 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #88.

Taylor Frigon Capital Management first reported a position in TEVA in Q4 2015 and has held it in 3 quarters since. 813 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

  • Taylor Frigon Capital Management held 69 shares of Teva Pharmaceuticals worth $3K as of Q2 2016.
  • Taylor Frigon Capital Management bought 52 Teva Pharmaceuticals shares in Q2 2016, an estimated $2.77K.
  • Teva Pharmaceuticals made up ﹤0.01% of Taylor Frigon Capital Management's portfolio in Q2 2016, its #88 holding.
  • Taylor Frigon Capital Management first reported a position in Teva Pharmaceuticals in Q4 2015 and has held it in 3 quarters since.
  • 813 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2016.

Based on Taylor Frigon Capital Management's 13F filing for Q2 2016, filed 3 Aug 2016.